Gln52 mutations in GNAO1-related disorders and personalized drug discovery

Katanaev, Vladimir

doi:10.1016/j.ebr.2023.100598

Scientific article

Comment

English

Gln52 mutations in GNAO1-related disorders and personalized drug discovery

ContributorsKatanaev, Vladimir

Published inEpilepsy & behavior reports, vol. 24, 100598

Publication date2023

Affiliation entities

Faculté de médecine / Section de médecine fondamentale / Département de physiologie cellulaire et métabolisme

Research groups

Voies de signalisation oncogéniques (998)

Citation (ISO format)

KATANAEV, Vladimir. Gln52 mutations in GNAO1-related disorders and personalized drug discovery. In: Epilepsy & behavior reports, 2023, vol. 24, p. 100598. doi: 10.1016/j.ebr.2023.100598

Article (Published version)

CC BY-NC-ND-4.0

Identifiers

PID : unige:173664
DOI : 10.1016/j.ebr.2023.100598

Additional URL for this publicationhttps://linkinghub.elsevier.com/retrieve/pii/S2589986423000163

Journal ISSN2589-9864

170views

92downloads

Creation07/12/2023 07:13:03

First validation07/12/2023 07:40:29

Update07/12/2023 07:40:29

Status update07/12/2023 07:40:29

Last indexation01/11/2024 06:59:21

Archive ouverte UNIGE

Gln52 mutations in GNAO1-related disorders and personalized drug discovery

Technical informations